{"name":"BGI Genomics","slug":"bgi-genomics","ticker":"300676.SZ","exchange":"SZSE","domain":"bgi.com","description":"BGI Group, formerly Beijing Genomics Institute, is a Chinese genomics company with headquarters in Yantian, Shenzhen. The company was originally formed in 1999 as a genetics research center to participate in the Human Genome Project. It also sequences the genomes of other animals, plants and microorganisms.","hq":"Shenzhen, China","founded":0,"employees":"3580","ceo":"Yin Ye","sector":"Genomic Sequencing / Life Sciences Tools","stockPrice":40.85,"stockChange":-1.33,"stockChangePercent":-3.15,"marketCap":"$2.5B","metrics":{"revenue":566259681.8011596,"revenueGrowth":20.4,"grossMargin":33.8,"rdSpend":0,"netIncome":-84520582.35149951,"cash":495886372.2344013,"dividendYield":0,"peRatio":255.3,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-28","type":"earnings","headline":"BGI Genomics Reports 2023 Annual Results","summary":"BGI Genomics reported a revenue increase of 15% year-over-year to CNY 5.6 billion in 2023, driven by strong demand for its genomic sequencing and analysis services.","drugName":"","sentiment":"positive"},{"date":"2023-09-01","type":"deal","headline":"BGI Genomics Partners with University of California to Develop New Genomic Sequencing Technologies","summary":"BGI Genomics has partnered with the University of California to develop new genomic sequencing technologies, further expanding its capabilities in the field.","drugName":"","sentiment":"neutral"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPQ1BSTTY0MU0wVFZfWDRNeGtRODRWTl80Q0xpNXZkOEdVSnM3SXhmakY5clZJdFB2a0otTVFuT0F4U1dPUHpfdDAyVFBZQzktby1KOXkxYUZRdUtTQXlRSHU2VkJYUkVQYXhYYnV0ckZfNlo2X2JLNVE4eV9ZRlYyRFhKNmxXblBnWHZHdHZ0WFFVQUg0VTJzTDBYcHlSMDcwSmZRQjlvVG1Idk5MTWZHV1lCd2ZUcVlVcG5fS3k1UHdYUQ?oc=5","date":"2026-01-15","type":"pipeline","source":"Reuters","summary":"BGI Genomics, Roche roll out diagnostic tests for Alzheimer's in China - Reuters","headline":"BGI Genomics, Roche roll out diagnostic tests for Alzheimer's in China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTFBoazVQS2VJVm9wZS1LdVZwVWF6T2xTamlOQklUX3dxS1hHZlRpODNEQ3VzQUR6MHBZdjZMWm04b3JOcmgyNmF0ZkxMRnpleWZjcGsweW5NWW91czB5?oc=5","date":"2025-09-05","type":"pipeline","source":"EurekAlert!","summary":"Families turn to genetics prevention as Duchenne therapies stall | DMD Day expert interview - EurekAlert!","headline":"Families turn to genetics prevention as Duchenne therapies stall | DMD Day expert interview - EurekAlert!","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPVWhwN0lsQ0R5cHZORU1Ma0gyUzlsQ2dJRkM0OUV0RFFGMjVRbkM5dnFhMFlWNElydG5CTkt2dElQVlJGSmVpTDFmVjJFVmlFT1JFNG9ZbTlZa3FiRXZKVkdSbEdLc1J1SjE0UjdYc1QxSHJ0UEpXUzYxdE9STzZMdzFxZFNWckRjLWstLVVubFFzd1l6U1dQcjZiSkFuVnNVR04tRnBRVEc5QQ?oc=5","date":"2024-04-02","type":"pipeline","source":"Philenews","summary":"Lawmakers urge Biden to call out more Chinese biotech firms - Philenews","headline":"Lawmakers urge Biden to call out more Chinese biotech firms","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxOZkpaekNQdEtzVEhYVEJLQmJwSjRmVEdXUEdQclgwdmNZR0RucThLa21ILUsxRE5fUkU2SU9EZ1J0d0dJa2h2VXFYQ1FhZUZfRUVTX0NxWkphXzNvTzVENFRnU2pKaWVNeFhZdmRGaVdHbDEtUzFEbXlOYXRyOU5IbmhiQVZOUUpzeThodHFhOGlxYUpvWUlHY29naHhCRjRGZDJJ?oc=5","date":"2023-03-16","type":"pipeline","source":"Reuters","summary":"US adds units of China's BGI, Inspur to trade blacklist - Reuters","headline":"US adds units of China's BGI, Inspur to trade blacklist","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxOQmRrbjRiTEtNMTRNV19CT3VYb3FPZzNHUHdEeHF0TUlnZTZfR0dmWTBXY1ZtMC1QQjlnelJZVi16ZzNCbEctVFJ0TFRCZUxTSzRQTWZrb3hnX3pFSlNUcTM5dWQ5OVpzNjdPVDczc3VLWHlOMldCUkFqdVJXRVRsZy0yQzJJUEJoQXM0ZUJaakQtV2lVUGNmdFo5RHpoeXI0OHNVZll3TGRPYmc?oc=5","date":"2022-03-12","type":"regulatory","source":"Reuters","summary":"China approves five COVID-19 antigen kits for self-testing - CCTV - Reuters","headline":"China approves five COVID-19 antigen kits for self-testing - CCTV","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxOSkpSazVKZ1hzNEVWMXlkNldhb09HSUdnTEZHNm1zX0pFcjQ1MUtVQi00UjBJQW1CNFdVSnZ3MFRqNVBmQS04Sm5qSVJHMmNOUXRTMkRyelRBN202ZWJLQjc5WUxDWjl0N0N3d3R4VWFWcTBiUkRURlk4RnBwUW1TbVdNSld0RzJ0MEdEZ3hGM2hiVXpNOUtveDFjdU5oaG9zZmlkZ3Rjc1dURDhNMWJ1bnNIUEZia3A3N1dHMVNSb0ozd3pQLV9CVkl6aWZkbFRSLUxNaDdHSTk5QmI5UDllTWNn?oc=5","date":"2021-06-24","type":"pipeline","source":"PR Newswire","summary":"Natera and BGI Genomics Announce Commercial Launch of the BGI/Natera Signatera Assay in China - PR Newswire","headline":"Natera and BGI Genomics Announce Commercial Launch of the BGI/Natera Signatera Assay in China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxQak80VENMMEJuQW1IVUhBSjZTTDV5cjR2cnBzMExfNU5WcGpkSG9PUjc4YjNlcllRYi1VYVpHY2FheHp2NV9UYko3MFpGd190SXhvMzluRnZhRzd0ZUM3X0JvTmhNX3h0b3psNE9nS0NKSi1kYVNWdTNSVUtmMHJPY3FJTEhsR3lUREVKckpseXlFRmtXOVBCLW5nemJtNkxrbUlKQmdkd0s1VUJ5czRyNkVQLVVpT3FKWjBlMVd6aFRkWjlzWlh2Rg?oc=5","date":"2020-05-06","type":"pipeline","source":"Reuters","summary":"China's BGI gets Australian foothold through mass coronavirus test delivery - Reuters","headline":"China's BGI gets Australian foothold through mass coronavirus test delivery","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxORkVQSTlXYkdqN3p3SE93OVVXODBwcEZDeDVGajhaMklNb1IyM1Fpb19zR0YyY25FNFdRejdVZi1sUFpWRHJ5X2wyNkdzNzJ4Q1lfVWFQRkF2NkpjOGVDdDNRVl9lNFgzdndERF8yb080UThmQU0xUDhCcHRNQTN2QWw4OGxoZ0NvMk1xS3RWNHl2QlZJa1BXTUhEOGo2NURhM0lnTmNZaDJraGw3dVlrWnZER25nTERNUm5vOXIwRVF3dw?oc=5","date":"2020-01-22","type":"pipeline","source":"Reuters","summary":"Chinese listed companies ramp up virus efforts after president's call - Reuters","headline":"Chinese listed companies ramp up virus efforts after president's call","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Illumina","Thermo Fisher Scientific","Qiagen"],"therapeuticFocus":["Genomic Sequencing","Life Sciences Research"],"financials":{"source":"yahoo_finance","revenue":546106202.538853,"revenuePeriod":"2025-12-31","revenueHistory":[{"period":"2025-12-31","value":546106202.538853},{"period":"2024-12-31","value":569913626.6569152},{"period":"2023-12-31","value":641057236.8852594},{"period":"2022-12-31","value":1039505844.7790617}],"grossProfit":205289212.92833096,"grossProfitHistory":[{"period":"2025-12-31","value":205289212.92833096},{"period":"2024-12-31","value":236355519.0828754},{"period":"2023-12-31","value":319907862.6563333},{"period":"2022-12-31","value":543385479.6844792}],"rdSpend":67334108.74994954,"rdSpendHistory":[{"period":"2025-12-31","value":67334108.74994954},{"period":"2024-12-31","value":89339074.23918204},{"period":"2023-12-31","value":77953884.33937673},{"period":"2022-12-31","value":78964309.98623869}],"sgaSpend":74939427.88713086,"operatingIncome":-25050432.16682818,"operatingIncomeHistory":[{"period":"2025-12-31","value":-25050432.16682818},{"period":"2024-12-31","value":-60312743.62652001},{"period":"2023-12-31","value":34096792.23128809},{"period":"2022-12-31","value":184473867.36281815}],"netIncome":-90883727.23164503,"netIncomeHistory":[{"period":"2025-12-31","value":-90883727.23164503},{"period":"2024-12-31","value":-133040177.06923372},{"period":"2023-12-31","value":13691824.86545035},{"period":"2022-12-31","value":118312986.74497178}],"eps":-1.4812,"epsHistory":[{"period":"2025-12-31","value":-1.4812},{"period":"2024-12-31","value":-2.189},{"period":"2023-12-31","value":0.2253},{"period":"2022-12-31","value":1.9562}],"cash":484226060.4662511,"cashHistory":[{"period":"2025-12-31","value":484226060.4662511},{"period":"2024-12-31","value":579882631.7403367},{"period":"2023-12-31","value":697466008.0675141},{"period":"2022-12-31","value":760449540.6158004}],"totalAssets":1731626914.022205,"totalLiabilities":463003909.801114,"totalDebt":94382246.44294041,"equity":1251896741.812997,"operatingCashflow":-9316715.380868861,"operatingCashflowHistory":[{"period":"2025-12-31","value":-9316715.380868861},{"period":"2024-12-31","value":14107799.453064954},{"period":"2023-12-31","value":60244929.45400752},{"period":"2022-12-31","value":19289810.550113972}],"capex":-74563866.75150071,"capexHistory":[{"period":"2025-12-31","value":-74563866.75150071},{"period":"2024-12-31","value":-78035794.21048687},{"period":"2023-12-31","value":-182220640.54845443},{"period":"2022-12-31","value":-186678182.89719987}],"freeCashflow":-83880582.13236958,"dividendsPaid":-2547369.7326778634,"buybacks":null,"employees":3580,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":32873398.85973212,"ebit":-817681.9507799657,"ebitda":-817681.9507799657,"period":"2026-03-31","revenue":119180804.82730497,"epsBasic":-0.0229,"netIncome":-1403150.8103688546,"rdExpense":13077659.447332716,"epsDiluted":-0.0229,"grossProfit":47325525.39290948,"operatingIncome":1001897.0367079302},{"sga":-36688703.647123724,"ebit":-79172750.57183926,"ebitda":-79172750.57183926,"period":"2025-12-31","revenue":152060592.38610777,"epsBasic":null,"netIncome":-87731675.02480975,"rdExpense":18283583.376576915,"epsDiluted":null,"grossProfit":35976214.07876898,"operatingIncome":-33270242.254559245},{"sga":null,"ebit":null,"ebitda":null,"period":"2025-09-30","revenue":null,"epsBasic":null,"netIncome":null,"rdExpense":null,"epsDiluted":null,"grossProfit":null,"operatingIncome":null},{"sga":-5198374.007733866,"ebit":9421514.64895132,"ebitda":9421514.64895132,"period":"2025-06-30","revenue":141421974.87598836,"epsBasic":null,"netIncome":8617904.523869924,"rdExpense":16252503.174906852,"epsDiluted":null,"grossProfit":64228083.89641398,"operatingIncome":12308379.352920562},{"sga":34898327.4052751,"ebit":-9711079.761267144,"ebitda":-9711079.761267144,"period":"2025-03-31","revenue":99027308.18868771,"epsBasic":-0.1278,"netIncome":-7766300.0677529415,"rdExpense":17292507.55598915,"epsDiluted":-0.1278,"grossProfit":43121877.4542755,"operatingIncome":-9012198.138911344},{"sga":-32980311.82262867,"ebit":-110580175.45716637,"ebitda":-110580175.45716637,"period":"2024-12-31","revenue":153422187.8305382,"epsBasic":null,"netIncome":-114740352.03148031,"rdExpense":30678952.78831919,"epsDiluted":null,"grossProfit":48036807.384310275,"operatingIncome":-55572916.98259527}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":40.85,"previousClose":42.18,"fiftyTwoWeekHigh":65,"fiftyTwoWeekLow":38.17,"fiftyTwoWeekRange":"38.17 - 65.0","fiftyDayAverage":41.37,"twoHundredDayAverage":47.37,"beta":0.76,"enterpriseValue":2112513413.6073215,"forwardPE":255.3,"priceToBook":2.02,"priceToSales":4.45,"enterpriseToRevenue":3.73,"enterpriseToEbitda":-268.08,"pegRatio":0,"ebitda":-7880289.24356996,"ebitdaMargin":-1.4,"freeCashflow":-46570578.33332832,"operatingCashflow":22479459.88479552,"totalDebt":88941724.18120128,"debtToEquity":7.1,"currentRatio":2.6,"returnOnAssets":-2.7,"returnOnEquity":-6.7,"analystRating":"","recommendationKey":"none","numberOfAnalysts":1,"targetMeanPrice":48.3,"targetHighPrice":48.3,"targetLowPrice":48.3,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0.73,"exDividendDate":1720051200,"insiderHeldPercent":39.4,"institutionHeldPercent":8.2,"sharesOutstanding":418317075,"floatShares":237705350,"sharesShort":0,"shortRatio":0,"shortPercentOfFloat":0,"epsTrailing":-1.38,"epsForward":0.16,"revenuePerShare":9.21,"bookValue":20.27,"officers":[{"age":47,"name":"Mr. Yujue  Wang","title":"CFO, Deputy GM & Non Independent Director"},{"age":41,"name":"Ms. Qian  Xu","title":"Director of Legal Affairs, General Counsel, Deputy GM & Secretary"},{"age":43,"name":"Mr. Hao  Li","title":"Deputy GM and Head of Marketing Center & i99 Division"},{"age":38,"name":"Mr. Shida  Zhu","title":"Deputy GM & Non Independent Director"}],"industry":"Diagnostics & Research","irWebsite":"","website":"https://www.bgi.com","phone":"86 400 706 6615"}}